Oral anticoagulant and antiplatelet. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Blood Platelets Plasma

Organisms4

Sea Cucumbers Seaweed Rabbits Phaeophyta

Diseases55

Hemorrhage Thromboembolism Thrombosis Thrombophlebitis Atrial Fibrillation Venous Thromboembolism Venous Thrombosis Stroke Pulmonary Embolism Postoperative Hemorrhage Thrombophilia Hematoma Blood Coagulation Disorders Embolism Cerebral Hemorrhage Recurrence Acute Coronary Syndrome Intracranial Hemorrhages Coronary Thrombosis Antiphospholipid Syndrome Myocardial Infarction Graft Occlusion, Vascular Postoperative Complications Heart Diseases Brain Ischemia Heart Valve Diseases Thrombocytopenia Cardiovascular Diseases Activated Protein C Resistance Acute Disease Cerebrovascular Disorders Ischemic Attack, Transient Ischemia Coronary Artery Disease Protein C Deficiency Protein S Deficiency Intracranial Thrombosis Purpura, Thrombocytopenic Antithrombin III Deficiency Carotid Artery Thrombosis Embolism, Cholesterol Coronary Disease Lupus Erythematosus, Systemic Gastrointestinal Hemorrhage Intracranial Embolism and Thrombosis Hypoprothrombinemias Blood Loss, Surgical Intracranial Embolism Hemorrhagic Disorders Peripheral Vascular Diseases Coagulation Protein Disorders Oral Hemorrhage Purpura, Thrombocytopenic, Idiopathic Hematoma, Subdural Hematoma, Subdural, Chronic

Chemicals and Drugs99

Anticoagulants Acenocoumarol Warfarin Platelet Aggregation Inhibitors beta-Alanine Phenprocoumon Phenindione Aspirin Vitamin K Thiophenes Ticlopidine Pyridones Antithrombins Factor Xa Benzimidazoles Heparin Heparin, Low-Molecular-Weight Lupus Coagulation Inhibitor Fibrinolytic Agents Prothrombin Protein C Blood Coagulation Factors Morpholines Vitamin K Epoxide Reductases Coumarins Thrombin Enoxaparin Rodenticides Dicumarol Thromboplastin Factor X 4-Hydroxycoumarins Coagulants Pyrazoles Protein S Thienopyridines Purinergic P2Y Receptor Antagonists Azetidines Thrombomodulin Receptors, Purinergic P2Y12 Factor VII Dipyridamole Amidines Fibrin Fibrinogen Degradation Products Antithrombin III Pyridines Hirudins Platelet Glycoprotein GPIIb-IIIa Complex Antibodies, Antiphospholipid Aryl Hydrocarbon Hydroxylases Antibodies, Anticardiolipin Heparin Antagonists Mixed Function Oxygenases Factor V beta 2-Glycoprotein I Factor Va Pipecolic Acids Tetrazoles Thromboxane B2 Adenosine Diphosphate Phosphodiesterase 3 Inhibitors Dermatan Sulfate Heparin Cofactor II Immunoglobulin Fab Fragments Hemostatics Purinergic P2 Receptor Antagonists Fibrinogen Cardiolipins Sulfinpyrazone Receptor, PAR-1 Fibrin Dalteparin Piperazines Autoantibodies Polysaccharides Arthropod Proteins P-Selectin Phenazopyridine Antithrombin Proteins Salivary Proteins and Peptides Thromboxanes Factor VIIa Recombinant Proteins Receptors, Thrombin Platelet Membrane Glycoproteins Factor VIIIa Fibrinopeptide A Citric Acid Cardiovascular Agents Drugs, Investigational Antifibrinolytic Agents Heparinoids Citrates Heparitin Sulfate Dilazep Phospholipids Ancrod Drug Combinations Antibodies, Monoclonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment47

International Normalized Ratio Administration, Oral Prothrombin Time Blood Coagulation Tests Drug Monitoring Partial Thromboplastin Time Treatment Outcome Drug Therapy, Combination Platelet Function Tests Perioperative Care Risk Factors Randomized Controlled Trials as Topic Oral Surgical Procedures Thrombin Time Heart Valve Prosthesis Prospective Studies Follow-Up Studies Pharmacovigilance Clinical Trials as Topic Risk Assessment Drug Substitution Drug Administration Schedule Retrospective Studies Thrombolytic Therapy Bleeding Time Stents Clinical Trials, Phase III as Topic Angioplasty, Balloon, Coronary Platelet Count Injections, Subcutaneous Incidence Drug-Eluting Stents Registries Vascular Surgical Procedures Tomography, X-Ray Computed Thrombelastography Whole Blood Coagulation Time Percutaneous Coronary Intervention Double-Blind Method Hirudin Therapy Blood Preservation Premedication Withholding Treatment Blood Specimen Collection Coronary Angiography Hemostatic Techniques Prosthesis Design

Psychiatry and Psychology1

Medication Adherence

Phenomena and Processes17

Prothrombin Time Blood Coagulation Partial Thromboplastin Time Platelet Aggregation Time Factors Thrombin Time Hemostasis Drug Interactions Platelet Activation Dose-Response Relationship, Drug Bleeding Time Platelet Count Drug Resistance Whole Blood Coagulation Time Fibrinolysis Platelet Adhesiveness Herb-Drug Interactions

Disciplines and Occupations1

Pharmacogenetics

Information Science3

Pharmacovigilance Incidence Registries

Named Groups1

Health Care27

Treatment Outcome Perioperative Care Risk Factors Randomized Controlled Trials as Topic Prospective Studies Follow-Up Studies Pharmacovigilance Clinical Trials as Topic Risk Assessment Drug Substitution Point-of-Care Systems Retrospective Studies Clinical Trials, Phase III as Topic Practice Guidelines as Topic Incidence Drug Utilization Medication Adherence Secondary Prevention Guideline Adherence Registries Rodent Control Physician's Practice Patterns Age Factors Cost-Benefit Analysis Comorbidity Double-Blind Method Withholding Treatment

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Anticoagulants Acenocoumarol Warfarin International Normalized Ratio Platelet Aggregation Inhibitors beta-Alanine Administration, Oral Prothrombin Time Hemorrhage Phenprocoumon Thromboembolism Phenindione Aspirin Vitamin K Thiophenes Ticlopidine Pyridones Thrombosis Thrombophlebitis Antithrombins Blood Coagulation Factor Xa Blood Coagulation Tests Benzimidazoles Atrial Fibrillation Venous Thromboembolism Heparin Heparin, Low-Molecular-Weight Drug Monitoring Lupus Coagulation Inhibitor Partial Thromboplastin Time Fibrinolytic Agents Prothrombin Venous Thrombosis Protein C Stroke Blood Coagulation Factors Morpholines Pulmonary Embolism Treatment Outcome Platelet Aggregation Drug Therapy, Combination Postoperative Hemorrhage Vitamin K Epoxide Reductases Platelet Function Tests Thrombophilia Hematoma Coumarins Thrombin Blood Coagulation Disorders Perioperative Care Embolism Enoxaparin Rodenticides Dicumarol Blood Platelets Thromboplastin Cerebral Hemorrhage Factor X Time Factors Risk Factors Randomized Controlled Trials as Topic 4-Hydroxycoumarins Oral Surgical Procedures Recurrence Coagulants Pyrazoles Acute Coronary Syndrome Intracranial Hemorrhages Thrombin Time Heart Valve Prosthesis Prospective Studies Hemostasis Drug Interactions Follow-Up Studies Protein S Thienopyridines Purinergic P2Y Receptor Antagonists Azetidines Platelet Activation Pharmacovigilance Thrombomodulin Receptors, Purinergic P2Y12 Clinical Trials as Topic Risk Assessment Coronary Thrombosis Drug Substitution Dose-Response Relationship, Drug Drug Administration Schedule Pharmacogenetics Factor VII Point-of-Care Systems Retrospective Studies Antiphospholipid Syndrome Thrombolytic Therapy Dipyridamole Amidines Myocardial Infarction Fibrin Fibrinogen Degradation Products Bleeding Time

No FAQ available that match "oral anticoagulant and antiplatelet"